Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS20070312HPVENSG00000148053.18protein_codingNTRK2YesNo4915Q16620
Q548C2
Q5VWE5
TVIS20039491HPVENSG00000148053.18protein_codingNTRK2YesNo4915Q16620
Q548C2
Q5VWE5
TVIS20063739HPVENSG00000148053.18protein_codingNTRK2YesNo4915Q16620
Q548C2
Q5VWE5
TVIS44010630HTLV-1ENSG00000148053.18protein_codingNTRK2YesNo4915Q16620
Q548C2
Q5VWE5
TVIS44008624HTLV-1ENSG00000148053.18protein_codingNTRK2YesNo4915Q16620
Q548C2
Q5VWE5
TVIS44005724HTLV-1ENSG00000148053.18protein_codingNTRK2YesNo4915Q16620
Q548C2
Q5VWE5
TVIS44026290HTLV-1ENSG00000148053.18protein_codingNTRK2YesNo4915Q16620
Q548C2
Q5VWE5
TVIS44020165HTLV-1ENSG00000148053.18protein_codingNTRK2YesNo4915Q16620
Q548C2
Q5VWE5
TVIS44017102HTLV-1ENSG00000148053.18protein_codingNTRK2YesNo4915Q16620
Q548C2
Q5VWE5
TVIS44003711HTLV-1ENSG00000148053.18protein_codingNTRK2YesNo4915Q16620
Q548C2
Q5VWE5
TCGA Plot Options
Drug Information
GeneNTRK2
DrugBank IDDB12010
Drug NameFostamatinib
Target IDBE0003605
UniProt IDQ16620
Regulation Typeinhibitor
PubMed IDs26516587
CitationsRolf MG, Curwen JO, Veldman-Jones M, Eberlein C, Wang J, Harmer A, Hellawell CJ, Braddock M: In vitro pharmacological profiling of R406 identifies molecular targets underlying the clinical effects of fostamatinib. Pharmacol Res Perspect. 2015 Oct;3(5):e00175. doi: 10.1002/prp2.175. Epub 2015 Sep 4.
GroupsApproved; Investigational
Direct ClassificationMethoxyanilines
SMILESCOC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Pathways
PharmGKB
ChEMBLCHEMBL2103830